Primoris Wealth Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,742
Closed -$222K 102
2025
Q1
$222K Sell
5,742
-199
-3% -$7.89K 0.17% 89
2024
Q4
$225K Sell
5,941
-923
-13% -$36.9K 0.17% 85
2024
Q3
$288K Sell
6,864
-99
-1% -$4.11K 0.21% 87
2024
Q2
$285K Sell
6,963
-99
-1% -$3.94K 0.23% 84
2024
Q1
$293K Sell
7,062
-174
-2% -$7.29K 0.23% 79
2023
Q4
$289K Buy
7,236
+1
+0% +$38 0.27% 74
2023
Q3
$283K Sell
7,235
-749
-9% -$29.8K 0.34% 57
2023
Q2
$324K Hold
7,984
0.36% 53
2023
Q1
$334K Sell
7,984
-49
-0.6% -$2.06K 0.41% 49
2022
Q4
$350K Sell
8,033
-199
-2% -$8.46K 0.54% 42
2022
Q3
$325K Sell
8,232
-324
-4% -$13.8K 0.58% 45
2022
Q2
$357K Buy
8,556
+1
+0% +$43 0.51% 48
2022
Q1
$391K Sell
8,555
-99
-1% -$4.39K 0.36% 51
2021
Q4
$416K Buy
+8,654
New +$410K 0.34% 60

Other funds holding BME

Primoris Wealth Advisors's BME Position: Q2 2025 in Review

Primoris Wealth Advisors sold out of BlackRock Health Sciences Trust (BME) in Q2 2025, closing a stake of 5,742 shares — an estimated $222K sold.

Primoris Wealth Advisors first reported a position in BME in Q4 2021 and held it in 14 quarters. The position peaked at $416K in Q4 2021. 72 funds tracked by Wall St. Rank hold BME as of Q2 2025.

  • Primoris Wealth Advisors reported no remaining BlackRock Health Sciences Trust position as of Q2 2025 after selling out during the quarter.
  • Primoris Wealth Advisors sold 5,742 BlackRock Health Sciences Trust shares in Q2 2025, an estimated $222K.
  • Primoris Wealth Advisors first reported a position in BlackRock Health Sciences Trust in Q4 2021 and held it in 14 quarters.
  • Primoris Wealth Advisors's BlackRock Health Sciences Trust position peaked at $416K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2025.

Based on Primoris Wealth Advisors's 13F filing for Q2 2025, filed 29 Jul 2025.